Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Rheumatology (Oxford, England)|January 5, 2021
Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort studyKarin Hellgren, Christine Ballegaard, Bénédicte Delcoigne, et al.
BMJ Open|March 31, 2026
Remote personalised exercise in axial spondyloarthritis: the SPARK trial - protocol for a 6-month randomised controlled trialBirgitte Nellemann, Camilla Fongen, Hanne Dagfinrud, et al.
The Journal of Rheumatology|September 1, 2024
Interstitial Lung Disease in Patients With Rheumatoid Arthritis or Psoriatic Arthritis Initiating Biologics and Controls: Data From 5 Nordic RegistriesSella Aarrestad Provan, Lotta Ljung, Eirik Klami Kristianslund, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 21, 2025
Recognition of Glycine Versus Nonglycine Citrulline Motifs Dictating the HLA Class II Association of Anticitrullinated Protein Antibodies: Insights From Autoantibody Profiling of 6,900 Scandinavian Patients With Rheumatoid ArthritisLinda Mathsson Alm, Helga Westerlind, Isabel Gehring, et al.
Arthritis Research & Therapy|October 18, 2025
A DNA methylation-based algorithm for diagnosing rheumatoid arthritisEspen Riskedal, Astanand Jugessur, Silje Watterdal Syversen, et al.
Annals of the Rheumatic Diseases|April 5, 2025
Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment armMerete Lund Hetland, Marte S Heiberg, Tuulikki Sokka-Isler, et al.
RMD Open|November 3, 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapySilje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 23, 2020
Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension TrialsKristin K Jørgensen, Guro L Goll, Joe Sexton, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 7, 2021
An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis: results from 19 countriesSilvia Rollefstad, Eirik Ikdahl, Grunde Wibetoe, et al.
The Lancet. Rheumatology|March 25, 2026
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trialJon Lampa, Dan Nordström, Ronald van Vollenhoven, et al.
Pageof 4